Annual EBITDA
-$22.82 M
+$867.00 K+3.66%
December 31, 2023
Summary
- As of February 7, 2025, MTNB annual EBITDA is -$22.82 million, with the most recent change of +$867.00 thousand (+3.66%) on December 31, 2023.
- During the last 3 years, MTNB annual EBITDA has risen by +$607.00 thousand (+2.59%).
- MTNB annual EBITDA is now -515.01% below its all-time high of -$3.71 million, reached on December 31, 2013.
Performance
MTNB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$4.14 M
+$1.46 M+26.10%
September 30, 2024
Summary
- As of February 7, 2025, MTNB quarterly EBITDA is -$4.14 million, with the most recent change of +$1.46 million (+26.10%) on September 30, 2024.
- Over the past year, MTNB quarterly EBITDA has increased by +$1.76 million (+29.83%).
- MTNB quarterly EBITDA is now -3590.45% below its all-time high of -$112.10 thousand, reached on March 31, 2013.
Performance
MTNB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$21.04 M
+$1.76 M+7.71%
September 30, 2024
Summary
- As of February 7, 2025, MTNB TTM EBITDA is -$21.04 million, with the most recent change of +$1.76 million (+7.71%) on September 30, 2024.
- Over the past year, MTNB TTM EBITDA has increased by +$1.39 million (+6.19%).
- MTNB TTM EBITDA is now -18672.52% below its all-time high of -$112.10 thousand, reached on March 31, 2013.
Performance
MTNB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MTNB EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.7% | +29.8% | +6.2% |
| 3 y3 years | +2.6% | +29.8% | +6.2% |
| 5 y5 years | -58.2% | +29.8% | +6.2% |
MTNB EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +4.7% | at high | +44.9% | at high | +20.3% |
| 5 y | 5-year | -25.8% | +4.7% | at high | +44.9% | -16.0% | +20.3% |
| alltime | all time | -515.0% | +4.7% | -3590.4% | +44.9% | <-9999.0% | +20.3% |
Matinas BioPharma Holdings EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.14 M(-26.1%) | -$21.04 M(-7.7%) |
| Jun 2024 | - | -$5.60 M(-1.1%) | -$22.80 M(-1.4%) |
| Mar 2024 | - | -$5.66 M(+0.3%) | -$23.13 M(+1.3%) |
| Dec 2023 | -$22.82 M(-3.7%) | -$5.65 M(-4.2%) | -$22.82 M(+1.8%) |
| Sep 2023 | - | -$5.90 M(-0.5%) | -$22.43 M(+3.1%) |
| Jun 2023 | - | -$5.92 M(+10.6%) | -$21.77 M(+1.1%) |
| Mar 2023 | - | -$5.36 M(+2.0%) | -$21.54 M(-9.1%) |
| Dec 2022 | -$23.69 M(-1.1%) | -$5.25 M(+0.4%) | -$23.69 M(-5.0%) |
| Sep 2022 | - | -$5.23 M(-8.1%) | -$24.95 M(-5.5%) |
| Jun 2022 | - | -$5.69 M(-24.2%) | -$26.40 M(+4.3%) |
| Mar 2022 | - | -$7.51 M(+15.4%) | -$25.31 M(+5.7%) |
| Dec 2021 | -$23.95 M(+2.2%) | -$6.51 M(-2.6%) | -$23.95 M(+0.9%) |
| Sep 2021 | - | -$6.68 M(+45.0%) | -$23.74 M(+5.6%) |
| Jun 2021 | - | -$4.61 M(-25.2%) | -$22.48 M(-4.1%) |
| Mar 2021 | - | -$6.16 M(-2.3%) | -$23.44 M(+0.0%) |
| Dec 2020 | -$23.43 M(+29.2%) | -$6.30 M(+16.3%) | -$23.43 M(+3.4%) |
| Sep 2020 | - | -$5.42 M(-2.8%) | -$22.67 M(+4.8%) |
| Jun 2020 | - | -$5.57 M(-9.4%) | -$21.63 M(+6.1%) |
| Mar 2020 | - | -$6.15 M(+11.0%) | -$20.38 M(+12.3%) |
| Dec 2019 | -$18.14 M(+25.7%) | -$5.54 M(+26.7%) | -$18.14 M(+8.6%) |
| Sep 2019 | - | -$4.37 M(+1.1%) | -$16.71 M(+9.7%) |
| Jun 2019 | - | -$4.32 M(+10.6%) | -$15.23 M(+6.8%) |
| Mar 2019 | - | -$3.91 M(-4.8%) | -$14.26 M(-1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$14.43 M(-12.0%) | -$4.10 M(+41.7%) | -$14.43 M(-3.2%) |
| Sep 2018 | - | -$2.90 M(-13.6%) | -$14.91 M(-3.1%) |
| Jun 2018 | - | -$3.35 M(-17.7%) | -$15.39 M(-3.8%) |
| Mar 2018 | - | -$4.07 M(-11.2%) | -$16.00 M(-2.4%) |
| Dec 2017 | -$16.40 M(+99.9%) | -$4.59 M(+35.8%) | -$16.40 M(+14.2%) |
| Sep 2017 | - | -$3.38 M(-14.8%) | -$14.37 M(+12.1%) |
| Jun 2017 | - | -$3.96 M(-11.4%) | -$12.81 M(+22.5%) |
| Mar 2017 | - | -$4.48 M(+75.4%) | -$10.46 M(+27.4%) |
| Dec 2016 | -$8.20 M(-16.9%) | -$2.55 M(+40.1%) | -$8.20 M(-2.6%) |
| Sep 2016 | - | -$1.82 M(+13.4%) | -$8.42 M(-3.7%) |
| Jun 2016 | - | -$1.61 M(-27.8%) | -$8.75 M(-8.2%) |
| Mar 2016 | - | -$2.22 M(-19.7%) | -$9.53 M(-3.4%) |
| Dec 2015 | -$9.87 M(-5.3%) | -$2.77 M(+29.1%) | -$9.87 M(-5.2%) |
| Sep 2015 | - | -$2.15 M(-10.3%) | -$10.41 M(-3.9%) |
| Jun 2015 | - | -$2.39 M(-6.5%) | -$10.83 M(-0.2%) |
| Mar 2015 | - | -$2.56 M(-22.7%) | -$10.85 M(+4.2%) |
| Dec 2014 | -$10.42 M(+180.9%) | -$3.31 M(+28.6%) | -$10.41 M(+16.9%) |
| Sep 2014 | - | -$2.57 M(+6.8%) | -$8.91 M(+14.4%) |
| Jun 2014 | - | -$2.41 M(+13.7%) | -$7.79 M(+36.2%) |
| Mar 2014 | - | -$2.12 M(+17.5%) | -$5.72 M(+54.1%) |
| Dec 2013 | -$3.71 M | -$1.80 M(+24.1%) | -$3.71 M(+94.7%) |
| Sep 2013 | - | -$1.45 M(+327.6%) | -$1.91 M(+321.6%) |
| Jun 2013 | - | -$339.80 K(+203.1%) | -$451.90 K(+303.1%) |
| Mar 2013 | - | -$112.10 K | -$112.10 K |
FAQ
- What is Matinas BioPharma Holdings annual EBITDA?
- What is the all time high annual EBITDA for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual EBITDA year-on-year change?
- What is Matinas BioPharma Holdings quarterly EBITDA?
- What is the all time high quarterly EBITDA for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings quarterly EBITDA year-on-year change?
- What is Matinas BioPharma Holdings TTM EBITDA?
- What is the all time high TTM EBITDA for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings TTM EBITDA year-on-year change?
What is Matinas BioPharma Holdings annual EBITDA?
The current annual EBITDA of MTNB is -$22.82 M
What is the all time high annual EBITDA for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual EBITDA is -$3.71 M
What is Matinas BioPharma Holdings annual EBITDA year-on-year change?
Over the past year, MTNB annual EBITDA has changed by +$867.00 K (+3.66%)
What is Matinas BioPharma Holdings quarterly EBITDA?
The current quarterly EBITDA of MTNB is -$4.14 M
What is the all time high quarterly EBITDA for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly EBITDA is -$112.10 K
What is Matinas BioPharma Holdings quarterly EBITDA year-on-year change?
Over the past year, MTNB quarterly EBITDA has changed by +$1.76 M (+29.83%)
What is Matinas BioPharma Holdings TTM EBITDA?
The current TTM EBITDA of MTNB is -$21.04 M
What is the all time high TTM EBITDA for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high TTM EBITDA is -$112.10 K
What is Matinas BioPharma Holdings TTM EBITDA year-on-year change?
Over the past year, MTNB TTM EBITDA has changed by +$1.39 M (+6.19%)